Home
NewsNewsAbu Dhabi University and FertiClinic Group have joined forces to establish the FertiClinic Reproductive Research Lab, an advanced reproductive research lab in Abu Dhabi housing IVF, andrology, and cryopreservation facilities. The partnership supports UAE national priorities, bridges academic and clinical expertise, and advances fertility innovation across the region.
A significant new chapter in UAE healthcare research has opened with the announcement of a formal partnership between Abu Dhabi University (ADU) and FertiClinic Fertilization Group. Together, the two institutions are establishing the FertiClinic Reproductive Research Lab at ADU's Abu Dhabi campus, an advanced reproductive research lab in Abu Dhabi that is set to serve as a dedicated platform for reproductive medicine research, clinical collaboration, and healthcare innovation.
The initiative directly supports the UAE's national development agenda, including the ambitious targets set out under 'We the UAE 2031' and UAE Centennial 2071, and aligns with the country's broader drive to build a research-driven healthcare ecosystem.
Housed within ADU's College of Health Sciences, the new facility will operate across three distinct laboratory environments, each addressing a critical area of reproductive science. The first is dedicated to in-vitro fertilization (IVF), the second to andrology, and the third to cryopreservation. Together, these units will form an integrated research environment equipped with advanced technologies and specialized embryological infrastructure.
The design of the facility reflects a deliberate focus on translational healthcare research, the kind of work that moves knowledge from the laboratory bench into meaningful clinical application. By combining cutting-edge equipment with direct access to fertility specialists, the lab is positioned to close the gap between academic discovery and patient care.
Professor Ghassan Aouad, Chancellor of Abu Dhabi University, placed the collaboration in the context of the university's long-term research mission. "Through this collaboration, Abu Dhabi University continues to strengthen its role in advancing impactful research, innovation, and industry collaboration in areas that directly contribute to healthcare advancement and societal wellbeing. The establishment of the FertiClinic Reproductive Research Lab reflects our commitment to providing students and researchers with access to advanced facilities and experiential learning opportunities that bridge academic knowledge with real-world healthcare applications. This commitment to research excellence is reflected in ADU's worldwide recognition, including ranking 75th globally and second in the UAE for research quality in the Times Higher Education World University Rankings 2026, highlighting the strength of our academic and research ecosystem."
That global ranking underscores why this advanced reproductive research lab in Abu Dhabi carries significance well beyond its immediate institutional context. ADU's standing as a research-intensive university gives the new facility an immediate foothold within a globally recognised academic environment.
Dr. Elsamawal El Hakim, CEO and Founder of FertiClinic Group, described the partnership as a milestone for both organisations and for the UAE's reproductive medicine landscape. "Through this strategic partnership with Abu Dhabi University, we are proud to contribute to the advancement of reproductive medicine, scientific research, and fertility innovation in the UAE. The establishment of the FertiClinic Reproductive Research Lab represents an important step toward bridging clinical excellence with academic research, while creating new opportunities for knowledge exchange, advanced training, and patient-centered innovation. We believe this collaboration will support the future of fertility care and reinforce Abu Dhabi's position as a regional leader in healthcare and medical research."
The partnership goes beyond the construction of a physical laboratory. It creates a structured framework for ongoing academic and clinical exchange. Faculty members and fertility specialists from both institutions will collaborate on scientific studies, contribute to medical publications, and jointly develop educational initiatives aimed at raising the standard of reproductive medicine training across the region.
Students stand to benefit directly as well. The lab will provide practical, hands-on learning opportunities through engagement with clinical experts and direct access to specialized laboratory environments, the kind of experiential education that is increasingly seen as essential for producing competent and confident healthcare professionals.
In addition, the facility will function as a regional events hub, hosting specialized workshops and conferences focused on reproductive health and fertility innovation. That programmatic dimension gives the advanced reproductive research lab in Abu Dhabi a convening role within the broader regional healthcare and research community, rather than simply functioning as an in-house facility.
The partnership has been explicitly designed to align with global sustainability and development priorities. The collaboration maps directly onto three United Nations Sustainable Development Goals: SDG 3 (Good Health and Well-being), SDG 4 (Quality Education), and SDG 17 (Partnerships for the Goals). This alignment reflects a conscious effort to embed the work of the FertiClinic Reproductive Research Lab within a framework of international responsibility and measurable societal impact.
That framing is significant. It positions the initiative not merely as an institutional arrangement between a university and a clinical group but as a contribution to the UAE's broader ambition to become a global hub for knowledge-driven healthcare. With Abu Dhabi increasingly asserting itself as a centre for medical research and innovation in the MENA region, the establishment of a dedicated advanced reproductive research lab in Abu Dhabi adds a concrete and strategically relevant piece of infrastructure to that emerging ecosystem.
The FertiClinic Reproductive Research Lab represents, in that sense, both a practical research facility and a statement of intent, one that signals where Abu Dhabi's academic and healthcare sectors are headed together.
A new Ipsos survey commissioned by Fertility Matters Canada finds 49% of Canadians with an opinion support a national baseline for IVF funding support, with backing rising to 59% among those aged 18–34. One in eight Canadians say cost has already forced them or someone close to delay or abandon fertility treatment.
Alpha Controls & Instrumentation Inc. has been selected by FertiTech Canada Inc. as its third-party calibration partner for Nilotech temperature probes. The partnership channels Canadian IVF laboratories and fertility clinics using Nilotech equipment to Alpha Controls for professional, accredited calibration services, while FertiTech continues to handle equipment supply and gas sensor calibration.
In the UK, a Ten Minute Rule Bill has been introduced in the Commons to create a legal right to paid time off for fertility treatment, aiming to standardize access to time‑sensitive appointments and reduce reliance on employer discretion. The proposal seeks House permission to proceed and spotlights workplace rights during Fertility Awareness Week.
Columbia University Fertility Center has achieved the first confirmed pregnancy using an AI-guided sperm recovery method in a man with azoospermia, as detailed in The Lancet. The STAR system combined advanced imaging, microfluidics, and robotics to retrieve two viable sperm, enabling embryo creation after prior failed surgical and manual attempts.
British Columbia's free IVF program exhausts 2025 funding within months of launch. At least one approved clinic stops accepting new applications. Applicants face aging-out risks and must wait until spring 2026 for next funding allocation.
Singapore’s MOH approves 13 additional genetic conditions for testing before embryos are implanted during IVF, enhancing reproductive genetic screening options.
National Health Service-funded IVF in England varies across regions in terms of access, cycle definitions, and eligibility. While Integrated Care Boards follow NICE guidelines, local implementation differs to meet specific population needs. Current policy reviews aim to enhance consistency and ensure continued access to fertility services across England.
